Inretio
Ischemic Stroke Treatment
StartupInretio is a Nir Am-based startup in the Health Tech & Life Sciences sector, established in 2017. Ischemic Stroke Treatment. The company has raised a total of $2.5M across 1 funding round, currently at the A stage. Inretio was founded by Raviv Vine. Key investors include Therma Bright. The company has 1-10 employees.
With $2.5M in total funding, Inretio is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StageA
- ProductR&D
- ModelB2B
- Employees1-10
- HQNir Am
- DistrictSouth District
- Last Round$2.5M
- Therma Bright
Raviv VineFounder & CEO
What does Inretio do?
Inretio develops solutions that address complications during clot retrieval procedures for ischemic stroke treatment.
How much funding has Inretio raised?
Inretio has raised $2.5M in total funding across 1 rounds. The company is currently at the A stage. Key investors include Therma Bright.
Who founded Inretio?
Inretio was founded in 2017 by Raviv Vine (Founder & CEO).
What sector is Inretio in?
Inretio operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Inretio located?
Inretio is based in Nir Am, Israel, South District.